683 Capital Management’s Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares BIOX.WS Stock Holding History

683 Capital Management’s Portfolio BIOX.WS Stock Details BIOX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200,000	Closed	-$42K	–	158
2020 Q2	$42K	Hold	200,000	–	–	﹤0.01%	138
2020 Q1	$28K	Hold	200,000	–	–	﹤0.01%	133
2019 Q4	$32K	Hold	200,000	–	–	﹤0.01%	163
2019 Q3	$68K	Hold	200,000	–	–	0.01%	131
2019 Q2	$66K	Hold	200,000	–	–	0.01%	145
2019 Q1	$54K	Buy	+200,000	New	+$47.9K	﹤0.01%	143

683 Capital Management's BIOX.WS Position: Q3 2020 in Review

683 Capital Management sold out of Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares (BIOX.WS) in Q3 2020, closing a stake of 200,000 shares — an estimated $42K sold.

683 Capital Management first reported a position in BIOX.WS in Q1 2019 and held it in 6 quarters. The position peaked at $68K in Q3 2019. 0 funds tracked by Wall St. Rank hold BIOX.WS as of Q3 2020.

683 Capital Management reported no remaining Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position as of Q3 2020 after selling out during the quarter.
683 Capital Management sold 200,000 Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares shares in Q3 2020, an estimated $42K.
683 Capital Management first reported a position in Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares in Q1 2019 and held it in 6 quarters.
683 Capital Management's Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position peaked at $68K in Q3 2019.
0 funds tracked by Wall St. Rank held Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares as of Q3 2020.

Based on 683 Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.